NMD Pharma company information, funding & investors | Dealroom.co
NMD Pharma raises €38M (~USD 47 Million) SERIES A Financing to Advance Treatments of Neuromuscular Disorders
Event: Aarhus - Brew Your Own: Meet the founders - Biopeople
Investors — NMD Pharma
NMD Pharma Initiates a Combined Phase I/IIa Clinical Trial of NMD670 for the Treatment of Symptoms of Myasthenia Gravis
Management — NMD Pharma
NMD Pharma
NMD Pharma company information, funding & investors | Dealroom.co
NMD Pharma - Inkef capital
Management — NMD Pharma
Nmd Pharma A/S, Aarhus N | firma | krak.dk
NMD Pharma
NMD Pharma is Strengthening Muscles in Neuromuscular Disorders
NMD Pharma Initiates a Combined Phase I/IIa Clinical Trial of NMD670 for the Treatment of Symptoms of Myasthenia Gravis
NMD Pharma
NMD Pharma brænder 41 mio. kr. af sin kæmpeinvestering
NMD Pharma is Strengthening Muscles in Neuromuscular Disorders
NMD Pharma - Capnova
Labiotech.eu on Twitter: "NMD Pharma, from @AarhusUni, is willing to tackle Neuromuscular Transmission Disorders #BioEquity2016… "
NMD Pharma company information, funding & investors | Dealroom.co
Management — NMD Pharma
Big deal: NMD flexes series A muscles - Global University Venturing
Nmd Pharma A/S, Aarhus N | firma | krak.dk
NMD bags €38M to run orphan neuromuscular disease trials | FierceBiotech
